
| Code | Targets | Indications | Preclinical | IND | Ph I | Ph II | Ph III | NDA/BLA |
|---|---|---|---|---|---|---|---|---|
| UB782 | / | Erectile dysfunction; Pulmonary arterial hypertension | ||||||
| UB696 | SLC6A19 | Chronic kidney disease; Phenylketonuria | ||||||
| UB677 | EPO | Anaemia in chronic kidney disease | ||||||
| UB333 | (BsAb) | IgA nephropathy | ||||||
| UB183 | Ion channel inhibitor | Diabetic nephropathy | ||||||
| UB095 | (siRNA) | Nephrotic syndrome | ||||||
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →